Therefore, given the known importance of MMP-2 and MMP-9 in tumor invasion, our findings suggest that the inhibitory effect of risedronate on osteosarcoma cell invasion is probably due to MMP inhibition rather than tumor cell death. Here, MMP2 is linked to osteosarcoma.